Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Jul 1;154(1):101–111. doi: 10.1084/jem.154.1.101

Phorbol myristate acetate stimulates phagosome-lysosome fusion in mouse macrophages

PMCID: PMC2186403  PMID: 7019380

Abstract

The effect of the tumor promoter phorbol myristate acetate (PMA) on phagosome-lysosome (P-L) fusion in mouse macrophages has been studied using a previously described (10) fluorescence assay. Treatment with 0.1--1.0 microgram PMA/ml caused a striking increase in the rate and extent of P-L fusion. Exposure of cells to phorbol, free myristate, or the monoesters of PMA did not reproduce this effect. Macrophages required from 2 to 3 h of pretreatment to express maximal P-L fusion, and this was maintained for at least 20 h when cells were returned to PMA-free medium. Catalase, superoxide dismutase, indomethacin, and hydrocortisone, agents that are known to block the effect of PMA on H2O2, O2-, prostaglandins, or plasminogen activator, did not affect the stimulation of P-L fusion by PMA. The protein-synthesis inhibitors puromycin and cycloheximide did block the PMA effect under conditions in which the high fusion rate of 4-d cells was not affected. Labeled PMA was rapidly taken up by macrophages, with a plateau of uptake at approximately 3 h. When cells were returned to PMA-free medium, cel- associated label was rapidly released, returning to background level within 1 h. The released label was found to be a metabolite of PMA by thin-layer chromatography. This product migrated between the monoester phorbol-12-myristate and free phorbol. Rapid metabolism of PMA was also observed by a macrophage cell line, J774, and, to a lesser extent, by primary rat embryo fibroblasts.

Full Text

The Full Text of this article is available as a PDF (662.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berry D. L., Lieber M. R., Fischer S. M., Slaga T. J. Qualitative and quantitative separation of a series of phorbol-ester tumor promoters by high-pressure liquid chromatography. Cancer Lett. 1977 Sep;3(3-4):125–132. doi: 10.1016/s0304-3835(77)94943-6. [DOI] [PubMed] [Google Scholar]
  2. Bonney R. J., Naruns P., Davies P., Humes J. L. Antigen-antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages. Prostaglandins. 1979 Oct;18(4):605–616. doi: 10.1016/0090-6980(79)90027-3. [DOI] [PubMed] [Google Scholar]
  3. Brune K., Glatt M., Kälin H., Peskar B. A. Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature. 1978 Jul 20;274(5668):261–263. doi: 10.1038/274261a0. [DOI] [PubMed] [Google Scholar]
  4. Driedger P. E., Blumberg P. M. Specific binding of phorbol ester tumor promoters. Proc Natl Acad Sci U S A. 1980 Jan;77(1):567–571. doi: 10.1073/pnas.77.1.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goren M. B. Phagocyte lysosomes: interactions with infectious agents, phagosomes, and experimental perturbations in function. Annu Rev Microbiol. 1977;31:507–533. doi: 10.1146/annurev.mi.31.100177.002451. [DOI] [PubMed] [Google Scholar]
  6. Jacobson K., Wenner C. E., Kemp G., Papahadjopoulos D. Surface properties of phorbol esters and their interaction with lipid monolayers and bilayers. Cancer Res. 1975 Nov;35(11 Pt 1):2991–2995. [PubMed] [Google Scholar]
  7. Johnston R. B., Jr, Godzik C. A., Cohn Z. A. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med. 1978 Jul 1;148(1):115–127. doi: 10.1084/jem.148.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kielian M. C., Cohn Z. A. Modulation of phagosome-lysosome fusion in mouse macrophages. J Exp Med. 1981 Apr 1;153(4):1015–1020. doi: 10.1084/jem.153.4.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kielian M. C., Cohn Z. A. Phagosome-lysosome fusion. Characterization of intracellular membrane fusion in mouse macrophages. J Cell Biol. 1980 Jun;85(3):754–765. doi: 10.1083/jcb.85.3.754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MATTHEWS J. S. Steroids. 223. Color reagent for steroids in thin-layer chromatography. Biochim Biophys Acta. 1963 Jan 1;69:163–165. doi: 10.1016/0006-3002(63)91237-x. [DOI] [PubMed] [Google Scholar]
  11. Nathan C. F., Root R. K. Hydrogen peroxide release from mouse peritoneal macrophages: dependence on sequential activation and triggering. J Exp Med. 1977 Dec 1;146(6):1648–1662. doi: 10.1084/jem.146.6.1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. O'Brien T. G., Diamond L. Metabolism of tritium-labeled 12-O-tetradecanoylphorbol-13-acetate by cells in culture. Cancer Res. 1978 Aug;38(8):2562–2566. [PubMed] [Google Scholar]
  13. Phaire-Washington L., Silverstein S. C., Wang E. Phorbol myristate acetate stimulates microtubule and 10-nm filament extension and lysosome redistribution in mouse macrophages. J Cell Biol. 1980 Aug;86(2):641–655. doi: 10.1083/jcb.86.2.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Phaire-Washington L., Wang E., Silverstein S. C. Phorbol myristate acetate stimulates pinocytosis and membrane spreading in mouse peritoneal macrophages. J Cell Biol. 1980 Aug;86(2):634–640. doi: 10.1083/jcb.86.2.634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ralph P., Prichard J., Cohn M. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity. J Immunol. 1975 Feb;114(2 Pt 2):898–905. [PubMed] [Google Scholar]
  16. Schmidt R., Hecker E. Autoxidation of phorbol esters under normal storage conditions. Cancer Res. 1975 May;35(5):1375–1377. [PubMed] [Google Scholar]
  17. Vassalli J. D., Hamilton J., Reich E. Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate. Cell. 1977 Jul;11(3):695–705. doi: 10.1016/0092-8674(77)90086-1. [DOI] [PubMed] [Google Scholar]
  18. Vassalli J. D., Hamilton J., Reich E. Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell. 1976 Jun;8(2):271–281. doi: 10.1016/0092-8674(76)90011-8. [DOI] [PubMed] [Google Scholar]
  19. Werb Z., Cohn Z. A. Cholesterol metabolism in the macrophage. II. Alteration of subcellular exchangeable cholesterol compartments and exchange in other cell types. J Exp Med. 1971 Dec 1;134(6):1570–1590. doi: 10.1084/jem.134.6.1570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yamasaki H., Mufson R. A., Weinstein I. B. Phorbol ester induced prostaglandin synthesis and [3H]-TPA metabolism by TPA-sensitive and TPA-resistant Friend erythroleukemia cells. Biochem Biophys Res Commun. 1979 Aug 13;89(3):1018–1025. doi: 10.1016/0006-291x(79)91878-3. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES